EWA
PPBT

EverSource Wealth Advisors’s Purple Biotech PPBT Stock Holding History

EverSource Wealth Advisors’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$37 – 4479
2025
Q4 		$37 Hold
6
– – ﹤0.01% 4194
2025
Q3 		$32 Buy
6
+4
+200% +$72 ﹤0.01% 4274
2025
Q2 		$38 Buy
+2
New +$49 ﹤0.01% 4205

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

EverSource Wealth Advisors's PPBT Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Purple Biotech (PPBT) in Q1 2026, closing a stake of 6 shares — an estimated $37 sold.

EverSource Wealth Advisors first reported a position in PPBT in Q2 2025 and held it in 3 quarters. The position peaked at $38 in Q2 2025. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • EverSource Wealth Advisors reported no remaining Purple Biotech position as of Q1 2026 after selling out during the quarter.
  • EverSource Wealth Advisors sold 6 Purple Biotech shares in Q1 2026, an estimated $37.
  • EverSource Wealth Advisors first reported a position in Purple Biotech in Q2 2025 and held it in 3 quarters.
  • EverSource Wealth Advisors's Purple Biotech position peaked at $38 in Q2 2025.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.